Michael Barbella, Managing Editor08.25.22
iRhythm Technologies Inc. has named Chad Patterson as chief commercial officer, replacing Dave Vort, who resigned earlier this summer. Vort is continuing with the company as a strategic advisor through March 31, 2023.
“We are grateful to Dave for his many contributions over the past eight and a half years, leading iRhythm from its early commercial days through periods of transformational growth,” said Quentin Blackford, iRhythm’s president and CEO. “Dave was instrumental in building our world-class commercial organization and has played a key role in our ongoing success. We thank Dave for all that he has done for iRhythm and look forward to his continued contributions as a strategic advisor.”
Patterson now manages the company’s commercial strategy, operations and execution. He most recently served as chief marketing officer at Dexcom Inc., where he played a critical role in strategic marketing initiatives to drive revenue growth across multiple geographies.
“As iRhythm expands within its core U.S. markets, into additional international geographies, and into adjacent markets, we are excited to welcome Chad to our executive team. Chad joins us at the perfect time to leverage his experience in driving significant growth in global markets as we look to execute against our renewed corporate strategy. With his track record of execution and wealth of experience, his data-driven approach to sales and marketing strategies and operations will allow us to continue to evolve as a market leader in the space,” said Blackford.
At Dexcom, Patterson was responsible for global product management, design, clinical education, customer experience, research, public relations, and healthcare provider and direct-to-consumer marketing. He played an instrumental role in driving revenue growth initiatives that resulted in the company growing from $400 million to forecasted revenues of approximately $2.9 billion for fiscal year 2022 as well as expanding beyond the United States and into more than 50 countries generating more than $750 million in annual international sales. Earlier in his career, Patterson served in various global strategic brand and product management roles with Nestlé in both the United States and Switzerland. In his last post, he was responsible for developing and executing the 10-year global business strategy of Nestle’s Coffee-Mate.
Patterson earned an MBA from the University of Southern California, Marshall School of Business, and a bachelor of arts degree from Gonzaga University, where he played Division I soccer.
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with proprietary algorithms that distill data from millions of heartbeats into clinically actionable information.
“We are grateful to Dave for his many contributions over the past eight and a half years, leading iRhythm from its early commercial days through periods of transformational growth,” said Quentin Blackford, iRhythm’s president and CEO. “Dave was instrumental in building our world-class commercial organization and has played a key role in our ongoing success. We thank Dave for all that he has done for iRhythm and look forward to his continued contributions as a strategic advisor.”
Patterson now manages the company’s commercial strategy, operations and execution. He most recently served as chief marketing officer at Dexcom Inc., where he played a critical role in strategic marketing initiatives to drive revenue growth across multiple geographies.
“As iRhythm expands within its core U.S. markets, into additional international geographies, and into adjacent markets, we are excited to welcome Chad to our executive team. Chad joins us at the perfect time to leverage his experience in driving significant growth in global markets as we look to execute against our renewed corporate strategy. With his track record of execution and wealth of experience, his data-driven approach to sales and marketing strategies and operations will allow us to continue to evolve as a market leader in the space,” said Blackford.
At Dexcom, Patterson was responsible for global product management, design, clinical education, customer experience, research, public relations, and healthcare provider and direct-to-consumer marketing. He played an instrumental role in driving revenue growth initiatives that resulted in the company growing from $400 million to forecasted revenues of approximately $2.9 billion for fiscal year 2022 as well as expanding beyond the United States and into more than 50 countries generating more than $750 million in annual international sales. Earlier in his career, Patterson served in various global strategic brand and product management roles with Nestlé in both the United States and Switzerland. In his last post, he was responsible for developing and executing the 10-year global business strategy of Nestle’s Coffee-Mate.
Patterson earned an MBA from the University of Southern California, Marshall School of Business, and a bachelor of arts degree from Gonzaga University, where he played Division I soccer.
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with proprietary algorithms that distill data from millions of heartbeats into clinically actionable information.